KIMBERLY APPLEGATE: Open Payments
NPI 1326313701 · WINCHESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,576 in 52 payments from 24 companies in 2025. Trend: 2023 $1,561 · 2024 $800 · 2025 $2,576
Food & beverage: $1,826Consulting: $750
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 4 | $920 |
| AstraZeneca Pharmaceuticals LP | 10 | $528 |
| Gilead Sciences, Inc. | 8 | $184 |
| Immunocore Limited | 4 | $179 |
| Janssen Biotech, Inc. | 5 | $135 |
| Amgen Inc. | 1 | $125 |
| Myriad Genetic Laboratories, Inc. | 1 | $79 |
| Iovance Biotherapeutics, Inc. | 1 | $46 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| Caris MPI, Inc. | 1 | $39 |
Products named: DATROWAY, Trodelvy, KIMMTRAK, IMDELLTRA (AMG757), IMFINZI, RYBREVANT, MYRISK, Amtagvi.
Industry payments across VA — which companies pay providers there.
